Anumana Secures FDA Clearance for AI ECG Detection Tool
CAMBRIDGE, Mass., March 28, 2026 Anumana, an AI-driven cardiovascular health technology company, announced that the U.S. Food and Drug...
Psoriasis
Advertisement
Takeda Zasocitinib Shows Strong Phase 3 Psoriasis Data
OSAKA, Japan and CAMBRIDGE, Mass., March 28, 2026 Takeda announced positive results from its Phase 3 LATITUDE clinical trials...
Innovent’s PECONDLE Gains NMPA Approval as China’s First IL-23p19 Antibody
SAN FRANCISCO & SUZHOU, China — November 28, 2025. Innovent Biologics has announced that PECONDLE® (picankibart injection), a recombinant...
Can-Fite Highlights Major Progress Across Late-Stage Drug Pipeline
Ramat Gan, Israel, November 26, 2025 — Can-Fite BioPharma has announced key updates across its advanced-stage clinical pipeline ahead...
Mabwell’s 9MW3011 Achieves Positive Phase III Results in Moderate-to-Severe Plaque Psoriasis
SHANGHAI, CHINA – November 11, 2025 — Mabwell (688062.SH), an innovative biopharmaceutical company specializing in biologics for major diseases,...
Advertisement
